VU
ZURA icon

Valence8 US’s Zura Bio ZURA Stock Holding History

Valence8 US’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,495
Closed -$71K – 61
2024
Q3 		$71K Buy
+17,495
New +$65.4K 0.03% 55

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Valence8 US's ZURA Position: Q4 2024 in Review

Valence8 US sold out of Zura Bio (ZURA) in Q4 2024, closing a stake of 17,495 shares — an estimated $71K sold.

Valence8 US first reported a position in ZURA in Q3 2024 and held it in 1 quarter. The position peaked at $71K in Q3 2024. 87 funds tracked by Wall St. Rank hold ZURA as of Q4 2024.

  • Valence8 US reported no remaining Zura Bio position as of Q4 2024 after selling out during the quarter.
  • Valence8 US sold 17,495 Zura Bio shares in Q4 2024, an estimated $71K.
  • Valence8 US first reported a position in Zura Bio in Q3 2024 and held it in 1 quarter.
  • Valence8 US's Zura Bio position peaked at $71K in Q3 2024.
  • 87 funds tracked by Wall St. Rank held Zura Bio as of Q4 2024.

Based on Valence8 US's 13F filing for Q4 2024, filed 12 Feb 2025.